Patient Engagement, Patient Satisfaction
Conditions
Keywords
Technology, Patient Education
Brief summary
The purpose of this study is to evaluate the effectiveness of providing patient medication education about Eliquis and Xarelto through an Amazon Alexa based voice recording.
Detailed description
Anticoagulants are considered high-risk medications due to the risk of major bleeding. The Federal Drug and Food Administration (FDA) MedWatch reporting system found that anticoagulants had the most adverse drug event (ADE) reports in 2011. Anticoagulants have also been reported as one of the leading drug classes contributing to emergency department visits3. Given the potential for serious adverse events, providing effective education to increase patient knowledge and awareness of those risks are essential. Incorporating technology into health care is becoming increasingly popular and has been shown to be effective for patient education. One reason is that technology can consistently provide complete patient education and is not subject to educator variability in providing this education.
Interventions
OTHERAmazon Alexa based voice recording patient education
Amazon Alexa based voice recording of medication education material
Sponsors
Cedars-Sinai Medical Center
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
(Patients): * 18 years of age or older * Have been prescribed either apixaban or rivaroxaban during their inpatient stay * Consent to participating in the study Inclusion Criteria (Nurses): * Providing direct patient care in select general medicine and orthopedic surgical units * Consent to participating in the study
Exclusion criteria
* Patients will be excluded if they have documented altered mental status, do not speak English, or are being prescribed rivaroxaban or apixaban on discharge only. * Nurses will be excluded if not providing direct patient care in select general medicine and orthopedic surgical units * Nurses declining participation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| % Change in pre- and post test scores | Within 72 hours of education | Effectiveness of Alexa based education by assessing understanding of Eliquis and Xarelto pre and post Alexa education |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| 7-day post-education retention rate | 1 week post discharge | Assess education retention rate 7-days after initial Alexa based education performed |
| Nursing satisfaction | 72 hours | Nursing satisfaction assessed by likert type scale questionnaire 1. How satisfied are you with the Alexa anticoagulation education process compared to standard of care? Responses: Very dissatisfied - Dissatisfied - Neutral - Satisfied - Very Satisfied 2. Do you agree or disagree that Alexa helps with your day-to-day workload? Responses: Strongly Agree - Agree - Neutral - Disagree - Strongly disagree |
| Patient satisfaction | 72 hours | Patient satisfaction assessed by likert type scale questionnaire 1. How satisfied are you with the anticoagulant education provided by Alexa? Responses: Very dissatisfied - Dissatisfied - Neutral - Satisfied - Very Satisfied 2. How strongly would you recommend using Alexa anticoagulant education to your friends, family and/or other patients? Responses: Highly recommend - Recommend - Neutral - Do not recommend |
Countries
United States
Outcome results
None listed